
  
    
      
        Introduction_NNP
        Transcriptional_NNP activation_NN is_VBZ one_CD of_IN the_DT key_JJ elements_NNS of_IN
        eukaryotic_JJ gene_NN expression_NN ._. A_DT variety_NN of_IN genetic_JJ ,_,
        biochemical_JJ ,_, and_CC structural_JJ studies_NNS have_VBP revealed_VBN many_JJ
        mechanistic_JJ details_NNS of_IN this_DT process_NN [_NN see_VB ,_, for_IN review_NN ,_, [_NN 1_CD 2_CD
        3_CD ]_NN ]_NN ._. In_IN some_DT cases_NNS ,_, the_DT structural_JJ /_NN chemical_NN basis_NN for_IN
        protein_NN /_NN DNA_NNP complex_JJ formation_NN and_CC recruitment_NN of_IN ancillary_JJ
        factors_NNS that_WDT promote_VBP transcription_NN have_VBP been_VBN elucidated_JJ ._.
        Mutational_NNP analysis_NN has_VBZ defined_VBN regions_NNS of_IN transcription_NN
        factors_NNS -_: even_RB specific_JJ residues_NNS -_: that_WDT participate_VBP in_IN the_DT
        activation_NN process_NN [_NN 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD ]_NN ._. One_CD of_IN the_DT most_RBS common_JJ
        structural_JJ features_NNS is_VBZ the_DT acidic_JJ activation_NN domain_NN ,_, a_DT
        region_NN with_IN excess_JJ negative_JJ charge_NN present_JJ on_IN many_JJ native_JJ
        activators_NNS as_RB well_RB as_IN artificial_JJ ones_NNS ._. These_DT activation_NN
        domains_NNS are_VBP modular_JJ and_CC can_MD be_VB effective_JJ when_WRB removed_VBN from_IN
        one_CD context_NN and_CC transplanted_VBN onto_IN other_JJ DNA_NNP binding_JJ
        molecules_NNS [_NN 10_CD 11_CD ]_NN ._.
        The_DT yeast_NN two-hybrid_JJ system_NN exploits_NNS this_DT modular_JJ
        feature_NN of_IN transcriptional_NN activators_NNS [_NN 12_CD 13_CD ]_NN ._. Several_JJ
        variants_NNS of_IN this_DT general_JJ approach_NN have_VBP been_VBN devised_VBN that_WDT
        employ_VBP DNA-binding_NNP domain_NN and_CC activation_NN domain_NN fusion_NN
        proteins_NNS to_TO assess_VB and_CC /_NN or_CC recover_VB proteins_NNS that_WDT interact_NN ._.
        The_DT exceptional_JJ flexibility_NN and_CC efficiency_NN of_IN this_DT system_NN
        propelled_VBD it_PRP to_TO the_DT forefront_NN of_IN protein_NN interaction_NN
        studies_NNS [_NN 14_CD 15_CD 16_CD ]_NN ._. The_DT technology_NN has_VBZ also_RB been_VBN adopted_VBN
        for_IN a_DT variety_NN of_IN other_JJ applications_NNS including_VBG protein-_NN RNA_NNP
        interactions_NNS ,_, small-molecule_JJ screens_NNS ,_, and_CC screens_NNS for_IN
        random_JJ peptide_NN aptamers_NNS [_NN 13_CD 17_CD 18_CD 19_CD ]_NN ._.
        In_IN this_DT study_NN we_PRP used_VBD the_DT DNA-binding_NNP domain_NN of_IN a_DT lexA_NN
        yeast_NN two-hybrid_JJ construct_VB to_TO recover_VB short_JJ peptides_NNS from_IN
        random_JJ peptide_NN libraries_NNS which_WDT function_VBP as_IN transcriptional_NN
        activators_NNS ._. A_DT deliberate_JJ search_NN for_IN activator_NN peptides_NNS
        revealed_VBD that_IN ,_, although_IN C-_NNP terminal_NN peptide_NN fusions_NNS to_TO the_DT
        lexA_NN DNA_NNP binding_JJ domain_NN had_VBD a_DT higher_JJR probability_NN of_IN
        activating_VBG transcription_NN ,_, sequences_NNS inserted_VBN within_IN the_DT
        structure_NN of_IN a_DT green_JJ fluorescent_NN protein_NN (_( GFP_NNP )_) scaffold_NN
        also_RB functioned_VBD as_IN activators_NNS ._. The_DT selected_VBN peptide_NN
        activators_NNS were_VBD strongly_RB biased_VBN in_IN amino_JJ acid_NN composition_NN
        compared_VBN to_TO unselected_JJ library_NN peptides_NNS ._. However_RB ,_,
        structural_JJ features_NNS such_JJ as_IN acidity_NN observed_VBD in_IN previous_JJ
        studies_NNS were_VBD not_RB absolute_JJ requirements_NNS for_IN activation_NN [_NN 11_CD
        20_CD 21_CD ]_NN ._. Charge_VB neutral_JJ and_CC basic_JJ peptide_NN activators_NNS arose_VBD
        at_IN significant_JJ frequencies_NNS ._. A_DT peptide_NN 11_CD residues_NNS in_IN length_NN
        was_VBD modular_JJ ,_, remaining_VBG a_DT competent_JJ activator_NN when_WRB grafted_VBN
        into_IN a_DT new_JJ context_NN ._. These_DT results_NNS are_VBP consistent_JJ with_IN the_DT
        recruitment_NN model_NN for_IN transactivation_NN and_CC suggest_VBP that_IN
        peptides_NNS may_MD act_VB as_IN bridging_VBG molecules_NNS [_NN 3_CD ]_NN ._. Such_JJ short_JJ
        peptidic_JJ sequences_NNS that_WDT activate_VBP transcription_NN may_MD be_VB
        useful_JJ in_IN the_DT context_NN of_IN drug_NN discovery_NN ._.
      
      
        Results_NNS
        
          Construction_NNP of_IN lexA_NN binding_JJ domain_NN peptide_NN
          libraries_NNS
          Two_CD random_JJ peptide_NN libraries_NNS were_VBD used_VBN in_IN the_DT
          experiments_NNS ,_, one_CD that_WDT displayed_VBD peptides_NNS within_IN the_DT green_JJ
          fluorescent_NN protein_NN (_( GFP_NNP )_) structure_NN ,_, the_DT other_JJ as_IN
          C-_NNP terminal_NN fusions_NNS to_TO lexA_NN ._. The_DT GFP_NNP internal_JJ random_JJ
          peptide_NN library_NN was_VBD fused_JJ to_TO the_DT lexA_NN DNA-binding_NNP domain_NN ,_,
          constructed_VBN according_VBG to_TO a_DT method_NN used_VBN previously_RB [_NN 22_CD ]_NN
          (_( Figure_NN 1_LS )_) ._. Each_DT clone_NN contained_VBD a_DT different_JJ random_JJ
          peptide_NN sequence_NN inserted_VBN within_IN a_DT loop_NN located_VBN 157_CD amino_JJ
          acids_NNS from_IN the_DT N-_NNP terminus_JJ which_WDT connects_VBZ two_CD of_IN the_DT beta_NN
          strands_NNS of_IN GFP_NNP ._. Thus_RB ,_, the_DT peptides_NNS were_VBD constrained_VBN at_IN
          either_DT end_NN by_IN the_DT structure_NN of_IN GFP_NNP ._. A_DT library_NN of_IN 8_CD
          million_CD random_JJ peptides_NNS of_IN length_NN 15_CD was_VBD created_VBN in_IN a_DT
          yeast_NN expression_NN vector_NN consisting_VBG of_IN a_DT 2_CD Î¼_NN circle_NN origin_NN ,_,
          a_DT selectable_JJ marker_NN ,_, and_CC the_DT yeast_NN 
          ADH_NNP 1_CD promotor_NN driving_VBG expression_NN of_IN
          the_DT hybrid_JJ proteins_NNS ._.
          Even_RB though_IN the_DT library_NN was_VBD biased_VBN at_IN the_DT DNA_NNP level_NN to_TO
          avoid_VB stop_VB codons_NNS (_( see_VB Methods_NNP )_) ,_, roughly_RB one_CD third_NN of_IN the_DT
          clones_NNS were_VBD expected_VBN to_TO contain_VB in-frame_JJ stop_NN codons_NNS
          within_IN the_DT insert_NN ,_, thus_RB producing_VBG a_DT truncated_JJ GFP_NNP
          molecule_NN containing_VBG only_RB the_DT first_JJ 157_CD amino_JJ acids_NNS of_IN GFP_NNP
          followed_VBN by_IN C-_NNP terminal_NN peptides_NNS of_IN variable_JJ length_NN up_IN to_TO
          15_CD amino_JJ acids_NNS ._. At_IN least_JJS some_DT of_IN these_DT truncated_JJ products_NNS
          were_VBD expressed_VBN at_IN high_JJ levels_NNS in_IN yeast_NN when_WRB fused_JJ to_TO lexA_NN
          (_( Caponigro_NNP ,_, unpublished_JJ )_) ._. The_DT characteristics_NNS of_IN the_DT
          library_NN sequences_NNS have_VBP been_VBN described_VBN previously_RB [_NN 22_CD ]_NN ._.
          No_DT dramatic_JJ sequence_NN biases_NNS were_VBD present_JJ ._.
          A_DT second_JJ library_NN in_IN which_WDT 15_CD residue-long_JJ random_JJ
          peptides_NNS were_VBD fused_JJ to_TO the_DT C-_NNP terminus_JJ of_IN the_DT lexA_NN binding_JJ
          domain_NN was_VBD also_RB constructed_VBN ._. This_DT library_NN was_VBD expressed_VBN
          from_IN a_DT vector_NN that_WDT contained_VBD a_DT centromere_NN ,_, a_DT selectable_JJ
          marker_NN ,_, and_CC the_DT 
          ADH_NNP 1_CD promotor_NN to_TO drive_VB expression_NN ._.
          Again_RB ,_, the_DT library_NN inserts_NNS were_VBD biased_VBN against_IN stop_NN
          codons_NNS as_IN for_IN the_DT internal_JJ peptide_NN library_NN ._. Sequence_NNP
          analysis_NN of_IN a_DT random_JJ set_NN of_IN 71_CD clones_NNS revealed_VBD an_DT average_JJ
          C-_NNP terminal_NN peptide_NN sequence_NN length_NN of_IN 11_CD ._. 7_CD residues_NNS ,_, with_IN
          no_DT discernible_JJ bias_NN for_IN or_CC against_IN particular_JJ amino_JJ acids_NNS
          (_( Table_NNP 1_LS )_) ._.
        
        
          Isolation_NNP of_IN lexA-peptide_JJ activators_NNS
          To_TO select_VB for_IN peptide_NN activators_NNS ,_, the_DT lexA-GFP_JJ /_NN peptide_NN
          and_CC lexA-peptide_JJ libraries_NNS were_VBD introduced_VBN separately_RB
          into_IN yeast_NN cells_NNS and_CC plated_JJ on_IN selective_JJ media_NNS ._. Only_RB
          cells_NNS that_WDT contained_VBD plasmids_NNS which_WDT activated_VBN expression_NN
          of_IN the_DT lexA-regulated_JJ 
          LEU_NNP 2_CD marker_NN grew_VBD ._. The_DT reversion_NN
          rate_NN for_IN the_DT assay_NN was_VBD low_JJ (_( <_NN 0_CD ._. 001_CD %_NN )_) ._. Based_VBN on_IN the_DT
          number_NN of_IN colonies_NNS per_IN plate_NN ,_, frequencies_NNS of_IN 0_CD ._. 02_CD %_NN of_IN
          activating_VBG peptides_NNS in_IN the_DT lexA-GFP_JJ /_NN peptide_NN library_NN and_CC
          0_CD ._. 1_CD %_NN in_IN the_DT C-_NNP terminal_NN library_NN were_VBD calculated_VBN ._.
          Plasmid_NNP DNA_NNP from_IN 131_CD individual_JJ lexA-GFP_JJ /_NN peptide_NN
          colonies_NNS and_CC 81_CD lexA-peptide_JJ colonies_NNS was_VBD recovered_VBN and_CC
          insert_VB DNA_NNP sequences_NNS obtained_VBN ._. For_IN the_DT lexA-GFP_JJ /_NN pep_NN
          library_NN ,_, these_DT sequences_NNS condensed_JJ to_TO 44_CD unique_JJ sequences_NNS
          with_IN only_RB 9_CD sequences_NNS present_JJ in_IN one_CD copy_NN (_( Table_NNP 2_LS )_) ._. The_DT
          remaining_VBG clones_NNS (_( 35_CD )_) were_VBD observed_VBN multiple_JJ times_NNS ;_: one_CD
          sequence_NN was_VBD seen_VBN 16_CD times_NNS (_( not_RB shown_VBN )_) ._. This_DT suggests_VBZ
          that_IN the_DT total_JJ population_NN of_IN unique_JJ sequences_NNS was_VBD
          relatively_RB small_JJ ._. Retests_NNP of_IN individual_JJ clones_NNS revealed_VBD
          that_DT ~_NN 90_CD %_NN were_VBD 
          bona_JJ fide_JJ activators_NNS ._. For_IN the_DT
          lexA-peptide_JJ library_NN ,_, only_RB 11_CD were_VBD observed_VBN multiple_JJ
          times_NNS ,_, leaving_VBG 55_CD single_JJ observations_NNS and_CC a_DT total_NN of_IN 66_CD
          unique_JJ sequences_NNS ._. Retests_NNP confirmed_VBD 100_CD %_NN (_( 16_CD /_NN 16_CD )_) as_IN true_JJ
          activators_NNS ._.
        
        
          Analysis_NNP of_IN peptide_NN activator_NN sequences_NNS
          Statistical_NNP analysis_NN of_IN the_DT activator_NN peptide_NN
          sequences_NNS from_IN both_DT libraries_NNS demonstrated_VBD biases_NNS in_IN
          amino_JJ acid_NN composition_NN and_CC net_JJ charge_NN ._. The_DT frequency_NN of_IN
          amino_JJ acids_NNS among_IN the_DT sequences_NNS was_VBD skewed_VBN significantly_RB
          toward_IN acidic_JJ residues_NNS (_( Table_NNP 1_LS )_) ._. For_IN the_DT
          lexA-GFP_JJ /_NN peptide_NN library_NN ,_, the_DT ratio_NN of_IN acidic_JJ residues_NNS to_TO
          basic_JJ residues_NNS (_( D_NNP +_NN E_NNP )_) /_NN (_( K_NNP +_NN R_NN )_) was_VBD about_IN two_CD (_( 63_CD /_NN 32_CD )_) ._.
          When_WRB the_DT net_JJ charge_NN (_( assuming_VBG D_NNP =_SYM E_NNP =_SYM -_: 1_CD ,_, K_NNP =_SYM R_NN =_SYM +_NN 1_LS )_) was_VBD
          calculated_VBN for_IN the_DT 27_CD sequences_NNS ,_, a_DT highly_RB significant_JJ
          bias_NN in_IN charge_NN distribution_NN was_VBD detected_VBN (_( Figures_NNS 2_CD ,_, 3_CD ,_,
          4_LS )_) ._. The_DT preponderance_NN of_IN negatively_RB charged_VBN sequences_NNS
          exceeded_VBD that_IN of_IN positively_RB charged_VBN ones_NNS by_IN a_DT factor_NN of_IN
          about_IN 2_CD (_( 15_CD vs_NNS ._. 8_CD )_) ._. However_RB ,_, one_CD clone_NN ,_, recovered_VBD 2_CD times_NNS
          and_CC confirmed_VBD as_IN an_DT activator_NN in_IN plasmid_NN linkage_NN tests_NNS ,_,
          had_VBD a_DT net_JJ charge_NN of_IN +_NN 3_CD ,_, and_CC there_EX was_VBD no_DT significant_JJ
          trend_NN toward_IN increased_VBN acidity_NN among_IN the_DT more_RBR frequent_JJ
          clones_NNS (_( not_RB shown_VBN )_) ._. For_IN the_DT lexA-peptide_JJ activator_NN set_VBD ,_,
          the_DT distribution_NN was_VBD even_RB more_RBR skewed_JJ ._. Negatively_NNP charged_VBD
          sequences_NNS exceeded_VBD positive_JJ ones_NNS by_IN a_DT factor_NN of_IN 5_CD (_( 45_CD vs_NNS ._.
          9_CD )_) ._. If_IN the_DT C-_NNP terminal_NN negative_JJ charge_NN was_VBD included_VBN ,_, the_DT
          disparity_NN was_VBD over_IN 6_CD -_: fold_VB ._. The_DT (_( D_NNP +_NN E_NNP )_) /_NN (_( K_NNP +_NN R_NN )_) ratio_NN for_IN
          this_DT sequence_NN set_VBN was_VBD about_IN 4_CD (_( 127_CD /_NN 31_CD )_) ._. However_RB ,_, there_EX
          were_VBD basic_JJ sequences_NNS among_IN the_DT set_VBN ._. For_IN example_NN ,_, of_IN the_DT
          16_CD sequences_NNS confirmed_VBD to_TO have_VB transcriptional_NN activator_NN
          activity_NN by_IN plasmid_NN linkage_NN tests_NNS ,_, one_CD was_VBD charge_NN neutral_JJ
          and_CC 2_CD were_VBD basic_JJ (_( +_NN 2_CD and_CC +_NN 1_CD ;_: Table_NNP 3_LS )_) ._. Compared_VBN with_IN
          amino_JJ acid_NN frequencies_NNS among_IN the_DT unselected_JJ lexA-peptide_JJ
          library_NN sequences_NNS ,_, there_EX was_VBD a_DT highly_RB significant_JJ
          increase_NN among_IN activators_NNS of_IN glutamate_NN ,_, leucine_NN ,_,
          phenylalanine_NN and_CC tryptophan_NN (_( 
          p_NN <_NN <_NN 0_CD ._. 001_CD )_) ._. Arginine_NNP was_VBD
          significantly_RB under-represented_JJ ._. A_DT bias_NN against_IN short_JJ
          peptides_NNS with_IN stop_NN codons_NNS that_WDT terminate_VB translation_NN
          before_IN the_DT 15_CD residue_NN limit_NN is_VBZ reached_VBN was_VBD observed_VBN among_IN
          the_DT lexA-peptide_JJ activators_NNS ._. The_DT mean_JJ length_NN of_IN
          activators_NNS was_VBD 15_CD ._. 1_LS amino_JJ acids_NNS compared_VBN to_TO a_DT length_NN of_IN
          11_CD ._. 7_CD in_IN the_DT unselected_JJ population_NN ._.
          We_PRP also_RB analyzed_VBD the_DT activator_NN sequences_NNS from_IN the_DT
          lexA-GFP_JJ /_NN peptide_NN library_NN which_WDT encoded_JJ truncated_JJ GFP_NNP
          sequences_NNS ._. Based_VBN on_IN their_PRP$ frequency_NN in_IN the_DT non-selected_JJ
          library_NN ,_, stop_VB codons_NNS were_VBD expected_VBN at_IN a_DT rate_NN of_IN 27_CD %_NN ._. Of_IN
          the_DT 44_CD unique_JJ sequences_NNS 32_CD %_NN (_( 14_CD /_NN 44_CD )_) contained_VBD stop_VB codons_NNS
          within_IN the_DT random_JJ peptide_NN sequence_NN ._. Thus_RB ,_, there_EX was_VBD
          neither_DT a_DT bias_NN toward_IN nor_CC against_IN truncated_JJ GFP_NNP molecules_NNS
          arising_VBG from_IN insert_NN stop_VB codons_NNS in_IN this_DT population_NN of_IN
          activators_NNS ._. However_RB ,_, 48_CD %_NN (_( 21_CD /_NN 44_CD )_) of_IN unique_JJ activator_NN
          sequences_NNS resulted_VBD in_IN truncated_JJ GFP_NNP due_JJ to_TO +_NN 1_CD or_CC -_: 1_CD
          frameshift_NN alterations_NNS within_IN the_DT random_JJ oligonucleotide_NN ._.
          Both_DT the_DT +_NN 1_CD and_CC -_: 1_CD frames_NNS hit_VBD stop_VB codons_NNS in_IN GFP_NNP within_IN
          10_CD amino_JJ acids_NNS of_IN the_DT random_JJ peptide_NN sequence_NN ._.
          Furthermore_RB ,_, from_IN the_DT total_JJ set_NN of_IN 44_CD unique_JJ sequences_NNS ,_,
          ~_NN 39_CD %_NN were_VBD +_NN 1_CD frameshifted_JJ ._. When_WRB two_CD sequences_NNS with_IN +_NN 1_CD
          frameshifted_JJ inserts_NNS were_VBD picked_VBN from_IN the_DT unselected_JJ
          random_JJ peptide_NN library_NN ,_, both_DT behaved_VBD as_IN activators_NNS (_( not_RB
          shown_VBN )_) ._. Together_RB ,_, these_DT results_NNS suggest_VBP that_DT translation_NN
          of_IN the_DT +_NN 1_CD frame_NN of_IN GFP_NNP ,_, after_IN the_DT random_JJ peptide_NN insert_NN ,_,
          results_NNS in_IN a_DT molecule_NN with_IN activator_NN properties_NNS ._.
        
        
          Modularity_NNP of_IN a_DT peptide_NN activator_NN
          One_CD of_IN the_DT peptide_NN activators_NNS from_IN the_DT
          lexA-GFP_JJ /_NN peptide_NN library_NN ,_, derived_VBN from_IN a_DT frameshift_NN in_IN
          the_DT insert_NN ,_, was_VBD tested_VBN for_IN its_PRP$ ability_NN to_TO activate_VBP
          transcription_NN when_WRB separated_JJ from_IN the_DT GFP_NNP structure_NN and_CC
          directly_RB fused_JJ to_TO the_DT lexA_NN binding_JJ domain_NN ._. This_DT sequence_NN ,_,
          termed_VBD Core-_NNP Activating_NNP Sequence_NNP (_( CAS_NNP )_) ,_, contained_VBD 11_CD amino_JJ
          acids_NNS (_( WSFWIQEWNQS_NNP )_) ,_, had_VBD a_DT net_JJ charge_NN of_IN -_: 1_CD ,_, and_CC three_CD
          tryptophan_NN residues_NNS ._. Five_CD of_IN the_DT amino_JJ acids_NNS were_VBD
          contributed_VBN by_IN out-of-frame_JJ translation_NN of_IN GFP_NNP ,_, one_CD from_IN
          the_DT random_JJ peptide_NN sequence_NN ,_, and_CC 5_CD from_IN the_DT 3_CD '_POS linker_NN
          used_VBD to_TO insert_VB the_DT random_JJ oligonucleotides_NNS for_IN library_NN
          construction_NN ._. An_DT expression_NN construct_VB was_VBD tested_VBN along_IN
          with_IN controls_NNS for_IN its_PRP$ ability_NN to_TO activate_VBP transcription_NN
          of_IN 
          LEU_NNP 2_CD ._. In_IN a_DT selection_NN for_IN the_DT 
          LEU_NNP 2_CD +_NN phenotype_NN ,_, roughly_RB
          equivalent_NN numbers_NNS of_IN colonies_NNS formed_VBN on_IN plates_NNS for_IN a_DT
          lexA-Gal_JJ 4_CD control_NN activator_NN protein_NN and_CC for_IN the_DT grafted_VBN
          peptide_NN ._. Furthermore_RB ,_, cell_NN patches_NNS revealed_VBD a_DT level_NN of_IN
          growth_NN similar_JJ to_TO the_DT Gal_NNP 4_CD control_NN (_( Figures_NNS 5_CD and_CC 6_CD )_) ._.
          Thus_RB ,_, CAS_NNP was_VBD as_IN potent_JJ a_DT transcriptional_NN activator_NN as_IN
          Gal_NNP 4_CD in_IN this_DT growth_NN assay_NN ._.
        
      
      
        Discussion_NNP
        In_IN general_JJ ,_, native_JJ transactivating_VBG domains_NNS are_VBP
        relatively_RB large_JJ ,_, dozens_NNS of_IN amino_JJ acids_NNS in_IN length_NN ._. However_RB ,_,
        fragments_NNS of_IN native_JJ activator_NN proteins_NNS have_VBP been_VBN described_VBN ._.
        An_DT 11_CD -_: amino-acid-long_JJ acidic_JJ domain_NN from_IN the_DT RelA_NNP subunit_NN
        of_IN NFÎº-B_NNP is_VBZ capable_JJ of_IN minimal_JJ activating_VBG behavior_NN when_WRB
        fused_JJ to_TO the_DT Gal_NNP 4_CD DNA-binding_NNP domain_NN (_( Gal_NNP 4_CD BD_NNP )_) [_NN 23_CD ]_NN ._. The_DT
        sequence_NN ,_, when_WRB joined_VBD together_RB in_IN tandem_JJ arrays_NNS ,_, is_VBZ as_RB
        potent_JJ as_IN the_DT wild_JJ type_NN RelA_NNP transactivator_NN ._. Wu_NNP et_CC al_NN ._.
        showed_VBD that_IN fragments_NNS of_IN the_DT Gal_NNP 4_CD activation_NN region_NN between_IN
        17_CD and_CC 41_CD amino_JJ acids_NNS in_IN length_NN provide_VB activation_NN
        functions_NNS of_IN a_DT magnitude_NN in_IN rough_JJ proportion_NN to_TO their_PRP$
        length_NN [_NN 24_CD ]_NN ._. This_DT result_NN suggests_VBZ that_IN short_JJ sequences_NNS
        are_VBP capable_JJ of_IN stimulating_VBG transcription_NN when_WRB complexed_JJ
        with_IN promotor_NN elements_NNS and_CC that_IN their_PRP$ effect_NN is_VBZ amplified_VBN
        by_IN increasing_VBG the_DT total_JJ content_NN of_IN such_JJ short_JJ
        sequences_NNS ._.
        A_DT series_NN of_IN papers_NNS has_VBZ explored_JJ properties_NNS of_IN random_JJ
        sequences_NNS ,_, including_VBG random_JJ peptides_NNS ,_, fused_JJ to_TO DNA_NNP binding_JJ
        domains_NNS in_IN the_DT context_NN of_IN transcriptional_NN activation_NN assays_NNS
        similar_JJ to_TO those_DT used_VBN in_IN the_DT two-hybrid_JJ system_NN ._. Ma_NNP and_CC
        Ptashne_NNP isolated_VBD a_DT set_NN of_IN 
        E_NNP ._. coli_NNS DNA_NNP fragments_NNS that_IN ,_, when_WRB
        fused_JJ to_TO Gal_NNP 4_CD BD_NNP ,_, promote_VB transcription_NN [_NN 11_CD ]_NN ._. All_DT (_( 15_CD /_NN 15_CD )_)
        active_JJ sequences_NNS examined_VBN by_IN the_DT authors_NNS encode_NN predicted_VBD
        polypeptides_NNS that_WDT are_VBP acidic_JJ ,_, and_CC a_DT peptide_NN as_RB small_JJ as_IN 12_CD
        amino_JJ acids_NNS was_VBD seen_VBN ._. One_CD sequence_NN (_( B_NNP 42_CD )_) ,_, 72_CD residues_NNS long_JJ ,_,
        was_VBD shown_VBN to_TO function_VB as_IN an_DT activator_NN when_WRB transferred_VBN to_TO
        the_DT lexA_NN DNA_NNP binding_JJ domain_NN ._. Yang_NNP et_CC al_NN ._. serendipitously_RB
        discovered_VBN among_IN a_DT set_NN of_IN retinoblastoma-binding_JJ peptides_NNS
        three_CD activators_NNS of_IN length_NN 16_CD residues_NNS that_WDT function_NN as_IN
        Gal_NNP 4_CD BD_NNP C-_NNP terminal_NN fusions_NNS [_NN 20_CD ]_NN ._. All_DT three_CD are_VBP acidic_JJ ,_,
        with_IN charge_NN -_: 3_CD or_CC -_: 4_CD ._. Giniger_NNP and_CC Ptashne_NNP found_VBD that_IN a_DT
        designed_VBN acidic_JJ ,_, amphipathic_JJ alpha_NN helix_NN of_IN 15_CD amino_JJ acids_NNS
        activates_NNS transcription_NN when_WRB fused_JJ to_TO the_DT Gal_NNP 4_CD BD_NNP [_NN 10_CD ]_NN ._.
        Using_VBG 
        in_IN vitro_NN transcription_NN assays_NNS ,_, Gerber_NNP
        et_CC al_NN ._. demonstrated_VBN that_IN homopolymeric_JJ stretches_NNS as_RB short_JJ
        as_IN 10_CD residues_NNS of_IN glutamine_NN or_CC proline_NN fused_JJ to_TO the_DT Gal_NNP 4_CD BD_NNP
        function_NN as_IN activators_NNS [_NN 25_CD ]_NN ._. Finally_RB ,_, Lu_NNP et_CC al_NN ._. screened_VBD
        for_IN C-_NNP terminal_NN Gal_NNP 4_CD BD_NNP peptides_NNS ,_, 8_CD amino_JJ acids_NNS long_JJ ._. Only_RB
        one_CD basic_JJ residue_NN was_VBD observed_VBN among_IN the_DT set_NN of_IN activator_NN
        peptides_NNS ,_, and_CC no_DT peptide_NN had_VBD a_DT net_NN predicted_VBD positive_JJ
        charge_NN [_NN 21_CD ]_NN ._.
        An_DT NMR_NNP structure_NN for_IN the_DT lexA_NN DNA-binding_NNP domain_NN has_VBZ
        been_VBN presented_VBN [_NN 26_CD ]_NN ._. The_DT structure_NN is_VBZ compact_NN and_CC
        globular_NN ,_, and_CC probably_RB interferes_VBZ only_RB minimally_RB with_IN fused_JJ
        transactivating_VBG sequences_NNS ._. In_IN addition_NN ,_, the_DT success_NN of_IN the_DT
        yeast_NN two-hybrid_JJ technique_NN suggests_VBZ that_IN the_DT geometric_JJ
        constraints_NNS on_IN transactivation_NN are_VBP not_RB severe_JJ (_( i_NNP ._. e_SYM ._. ,_, the_DT
        DNA-binding_NNP elements_NNS and_CC the_DT transactivating_VBG portion_NN of_IN the_DT
        molecule_NN (_( or_CC complex_JJ )_) do_VBP not_RB require_VB precise_JJ positioning_NN
        with_IN respect_NN to_TO each_DT other_JJ )_) ._. Because_IN Gal_NNP 4_CD -_: GFP_NNP fusions_NNS are_VBP
        unstable_JJ ,_, we_PRP were_VBD unable_JJ to_TO analyze_VB the_DT GFP_NNP /_NN peptide_NN
        insertions_NNS identified_VBN in_IN the_DT lexA_NN hybrid_JJ proteins_NNS in_IN the_DT
        context_NN of_IN the_DT Gal_NNP 4_CD BD_NNP (_( not_RB shown_VBN )_) ._. However_RB ,_, a_DT peptide_NN
        selected_VBN in_IN the_DT context_NN of_IN the_DT amino_JJ terminal_NN portion_NN of_IN
        GFP_NNP functioned_VBD effectively_RB when_WRB this_DT GFP_NNP segment_NN was_VBD
        removed_VBN and_CC the_DT peptide_NN was_VBD grafted_VBN directly_RB onto_IN lexA_NN ._. Due_JJ
        to_TO differences_NNS in_IN expression_NN levels_NNS among_IN C-_NNP terminal_NN and_CC
        internal_JJ GFP_NNP peptide_NN constructs_NNS ,_, we_PRP did_VBD not_RB consider_VB it_PRP
        useful_JJ to_TO pursue_VB more_RBR quantitative_JJ transactivation_NN studies_NNS
        [_NN 22_CD 27_CD ]_NN ._.
        Activator_NNP peptides_NNS were_VBD present_JJ in_IN the_DT two_CD libraries_NNS at_IN
        remarkably_RB high_JJ frequencies_NNS -_: 10_CD -_: 3_CD in_IN the_DT case_NN of_IN the_DT
        C-_NNP terminal_NN library_NN ,_, approximately_RB the_DT same_JJ frequency_NN
        observed_VBN by_IN Lu_NNP et_CC al_NN ._. [_NN 21_CD ]_NN ._. The_DT 5_CD -_: fold_VB lower_JJR frequency_NN
        of_IN activators_NNS in_IN the_DT lexA-GFP_JJ /_NN peptide_NN library_NN may_MD indicate_VB
        a_DT role_NN for_IN the_DT C-_NNP terminal_NN negative_JJ charge_NN ,_, the_DT specific_JJ
        geometry_NN ,_, or_CC the_DT conformational_NN flexibility_NN of_IN the_DT fused_JJ
        (_( vs_NNS ._. inserted_VBN )_) peptides_NNS ._. Considerably_NNP more_JJR than_IN half_NN of_IN the_DT
        activator_NN sequences_NNS we_PRP observed_VBD had_VBD a_DT large_JJ excess_NN of_IN
        negative_JJ charge_NN ,_, a_DT finding_VBG that_WDT is_VBZ consistent_JJ with_IN the_DT
        involvement_NN of_IN acidic_JJ residues_NNS in_IN the_DT activation_NN process_NN [_NN
        11_CD ]_NN ._. However_RB ,_, we_PRP observed_VBD several_JJ examples_NNS of_IN charge_NN
        neutral_JJ and_CC basic_JJ peptides_NNS (_( Table_NNP 3_LS )_) ._. As_IN a_DT group_NN ,_, the_DT
        sequences_NNS did_VBD not_RB display_VB obvious_JJ patterns_NNS of_IN amphipathic_JJ
        helicity_NN based_VBN on_IN the_DT lack_NN of_IN 3_CD ,_, 4_CD or_CC 7_CD repeat_NN units_NNS ._.
        Glutamine_NNP and_CC proline_NN residues_NNS were_VBD not_RB significantly_RB
        over-represented_JJ in_IN the_DT sequence_NN set_VBN ._. Instead_RB ,_, in_IN addition_NN
        to_TO glutamate_NN ,_, large_JJ hydrophobic_JJ amino_JJ acids_NNS were_VBD abundant_JJ ._.
        This_DT result_NN accords_NNS with_IN mutagenesis_NNS experiments_NNS that_WDT have_VBP
        pinpointed_JJ acidic_JJ residues_NNS and_CC phenylalanine_NN as_IN special_JJ
        contributors_NNS to_TO transactivation_NN [_NN 23_CD 28_CD ]_NN ._.
        Two_CD questions_NNS are_VBP raised_VBN by_IN our_PRP$ and_CC other_JJ studies_NNS of_IN
        peptide_NN activators_NNS :_: (_( i_NNP )_) what_WP is_VBZ the_DT minimum_JJ size_NN of_IN an_DT
        activator_NN ?_. and_CC ,_, (_( ii_NN )_) what_WP is_VBZ the_DT significance_NN of_IN the_DT
        extreme_JJ sequence_NN diversity_NN evidenced_VBN by_IN transactivating_VBG
        peptides_NNS ?_. We_PRP identified_VBD and_CC tested_VBD an_DT 11_CD -_: residue-long_JJ
        activator_NN that_WDT functioned_VBD in_IN two_CD different_JJ contexts_NNS :_: at_IN the_DT
        C-_NNP terminus_JJ of_IN a_DT truncated_JJ GFP_NNP molecule_NN and_CC attached_VBN
        directly_RB to_TO lexA_NN ._. Because_IN we_PRP did_VBD not_RB direct_JJ our_PRP$ screen_NN at_IN
        smaller_JJR peptides_NNS ,_, we_PRP suspect_VBP that_IN a_DT deliberate_JJ effort_NN to_TO
        identify_VB smaller_JJR activators_NNS would_MD be_VB fruitful_JJ ._. Indeed_RB ,_, Lu_NNP
        et_CC al_NN ._. found_VBD 8_CD -_: mer_NN activators_NNS ,_, though_IN none_NN was_VBD tested_VBN for_IN
        modularity_NN [_NN 21_CD ]_NN ._. Nonetheless_RB ,_, the_DT tendency_NN for_IN
        C-_NNP terminal_NN activators_NNS to_TO be_VB longer_RBR than_IN the_DT average_JJ library_NN
        peptide_NN suggests_VBZ a_DT preference_NN for_IN length_NN in_IN the_DT
        transactivation_NN function_NN [_NN 24_CD ]_NN ._.
        The_DT recruitment_NN model_NN for_IN transcriptional_NN activation_NN
        stipulates_VBZ that_IN eukaryotic_JJ transcription_NN is_VBZ driven_VBN mainly_RB
        by_IN recruitment_NN of_IN preformed_JJ RNA_NNP polymerase_NN holoenzyme_NN to_TO
        specific_JJ sites_NNS on_IN the_DT DNA_NNP [_NN 3_CD ]_NN ._. According_VBG to_TO this_DT model_NN ,_,
        peptides_NNS may_MD bind_NN one_CD of_IN numerous_JJ proteins_NNS that_WDT guide_NN
        holoenzyme_NN to_TO the_DT lexA_NN binding_JJ site_NN ._. Such_JJ proteins_NNS include_VBP
        components_NNS of_IN holoenzyme_NN and_CC perhaps_RB other_JJ factors_NNS [_NN see_VB
        ref_NN ._. [_NN 3_CD ]_NN ]_NN ._. Short_JJ peptides_NNS can_MD bind_NN proteins_NNS with_IN
        reasonably_RB high_JJ affinity_NN (_( see_VB ref_NN ._. [_NN 28_CD ]_NN ,_, for_IN review_NN )_) ._.
        Because_IN transactivation_NN is_VBZ a_DT process_NN that_WDT involves_VBZ
        protein-protein_JJ interactions_NNS ,_, it_PRP is_VBZ not_RB surprising_JJ that_IN
        peptides_NNS linked_VBN to_TO DNA-binding_NNP domains_NNS function_VBP as_IN
        transactivators_NNS by_IN bridging_VBG interactions_NNS that_WDT promote_VBP
        transcription_NN ._.
        The_DT wide_JJ range_NN of_IN primary_JJ sequences_NNS and_CC sequence_NN
        features_NNS described_VBD to_TO date_NN among_IN peptide_NN activators_NNS
        supports_VBZ the_DT recruitment_NN model_NN ._. Given_VBN the_DT diversity_NN of_IN
        proteins_NNS that_WDT comprise_VBP holoenzyme_NN ,_, this_DT model_NN implies_VBZ that_IN
        many_JJ sequences_NNS of_IN different_JJ types_NNS would_MD be_VB competent_JJ
        activators_NNS ;_: their_PRP$ sole_JJ requirement_NN would_MD be_VB to_TO bind_NN
        proteins_NNS within_IN holoenzyme_NN [_NN 3_CD ]_NN ._. The_DT acidic_JJ peptides_NNS may_MD
        interact_NN in_IN a_DT manner_NN akin_JJ to_TO native_JJ activators_NNS [_NN 7_CD ]_NN ._. But_CC
        the_DT basic_JJ ones_NNS may_MD ,_, for_IN example_NN ,_, bind_NN other_JJ proteins_NNS that_WDT
        contain_VBP acidic_JJ regions_NNS ,_, thereby_RB forming_VBG a_DT bridge_NN to_TO
        holoenzyme_NN ._. Alternatively_RB ,_, these_DT basic_JJ peptides_NNS may_MD bind_NN
        different_JJ regions_NNS of_IN the_DT holoenzyme_NN component_NN (_( s_VBZ )_) recognized_VBN
        by_IN acidic_JJ peptides_NNS ,_, or_CC entirely_RB different_JJ subunits_NNS [_NN 21_CD ]_NN
        ._.
        Apart_RB from_IN scientific_JJ interest_NN ,_, these_DT findings_NNS may_MD have_VB
        value_VB in_IN creating_VBG tools_NNS for_IN drug_NN and_CC drug_NN target_NN discovery_NN
        using_VBG the_DT yeast_NN two-hybrid_JJ system_NN ._. Isolation_NNP of_IN a_DT panel_NN of_IN
        small_JJ peptides_NNS with_IN different_JJ structural_JJ properties_NNS could_MD
        improve_VB the_DT performance_NN of_IN the_DT system_NN by_IN providing_VBG an_DT
        option_NN for_IN multiple_JJ screens_NNS using_VBG a_DT variety_NN of_IN peptides_NNS ._.
        This_DT option_NN might_MD decrease_VB false_JJ negatives_NNS and_CC false_JJ
        positives_NNS if_IN applied_VBN intelligently_RB ._. For_IN example_NN ,_, a_DT series_NN
        of_IN positively_RB charged_VBN ,_, negatively_RB charged_VBN and_CC neutral_JJ
        peptides_NNS may_MD enhance_VB the_DT accuracy_NN of_IN the_DT method_NN ._. In_IN
        addition_NN ,_, short_JJ activating_VBG sequences_NNS may_MD prove_VB useful_JJ in_IN
        the_DT context_NN of_IN isolating_VBG peptides_NNS that_WDT interact_NN with_IN other_JJ
        proteins_NNS ._. Peptides_NNP that_DT bind_NN specific_JJ proteins_NNS of_IN
        therapeutic_JJ interest_NN in_IN the_DT yeast_NN two-hybrid_JJ system_NN have_VBP a_DT
        variety_NN of_IN applications_NNS in_IN drug_NN development_NN ._. These_DT peptides_NNS
        could_MD be_VB used_VBN as_IN lead-ins_JJ for_IN creation_NN of_IN peptido-mimetics_JJ ._.
        Alternatively_RB ,_, they_PRP might_MD provide_VB reagents_NNS for_IN
        high-throughput_JJ displacement_NN screens_NNS [_NN 30_CD ]_NN ._. Typically_RB ,_,
        such_JJ peptides_NNS are_VBP isolated_VBN from_IN libraries_NNS on_IN the_DT activation_NN
        domain_NN of_IN the_DT two_CD hybrid_JJ system_NN [_NN 12_CD ]_NN ._. By_IN substituting_VBG
        small_JJ pepticals_NNS for_IN the_DT activation_NN function_NN ,_, it_PRP may_MD be_VB
        possible_JJ to_TO define_VB binding_JJ sites_NNS with_IN higher_JJR resolution_NN in_IN
        the_DT context_NN ,_, for_IN instance_NN ,_, of_IN the_DT reverse_JJ two-hybrid_JJ
        approach_NN [_NN 18_CD ]_NN ;_: Caponigro_NNP et_CC al_NN ._. ,_, unpublished_JJ )_) ._. Small_JJ
        peptides_NNS active_JJ in_IN the_DT yeast_NN two-hybrid_JJ system_NN may_MD be_VB
        synthesized_JJ by_IN Merrifield_NNP procedures_NNS ,_, labeled_VBN ,_, and_CC used_VBD
        directly_RB in_IN screens_NNS for_IN small_JJ molecules_NNS [_NN 30_CD ]_NN ._. This_DT
        approach_NN might_MD avoid_VB laborious_JJ testing_NN of_IN hybrid_JJ
        protein_NN /_NN peptides_NNS to_TO determine_VB which_WDT peptides_NNS bind_NN
        independent_JJ of_IN their_PRP$ fusion_NN partner_NN ._. Finally_RB ,_, non-peptidic_JJ
        molecules_NNS that_WDT bind_NN in_IN a_DT sequence-specific_JJ manner_NN to_TO DNA_NNP
        have_VBP been_VBN fused_JJ to_TO 20_CD -_: and_CC 16_CD -_: residue_NN peptides_NNS ._. These_DT
        hybrid_JJ molecules_NNS activate_VBP transcription_NN [_NN 9_CD 31_CD ]_NN ._. It_PRP may_MD
        be_VB possible_JJ to_TO produce_VB small-molecule_JJ activators_NNS (_( or_CC
        repressors_NNS )_) that_DT bind_NN DNA_NNP specifically_RB ,_, but_CC also_RB activate_VBP
        transcription_NN of_IN adjacent_JJ genes_NNS through_IN a_DT non-peptidic_JJ ,_,
        more_RBR drug-like_JJ moiety_NN ._.
      
      
        Conclusions_NNP
        Peptide_NNP activators_NNS are_VBP recovered_VBN from_IN random_JJ peptide_NN
        libraries_NNS at_IN high_JJ frequency_NN ._. These_DT peptides_NNS display_VBP
        significant_JJ sequence_NN biases_NNS toward_IN negative_JJ charge_NN ._.
        However_RB ,_, basic_JJ activator_NN peptides_NNS are_VBP also_RB present_JJ in_IN the_DT
        set_VBN ._. These_DT results_NNS are_VBP consistent_JJ with_IN the_DT recruitment_NN
        model_NN of_IN transcriptional_NN activation_NN in_IN eukaryotes_NNS and_CC
        support_VB the_DT idea_NN that_IN small_JJ molecules_NNS directed_VBN at_IN the_DT
        transcription_NN process_NN may_MD prove_VB to_TO be_VB a_DT useful_JJ therapeutic_JJ
        strategy_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        Yeast_NN strain_NN yVT_NN 87_CD (_( EGY_NNP 48_CD (_( Clontech_NNP )_) MATa_NNP ,_, ura_NN 3_CD ,_, his_PRP$ 3_CD ,_,
        trp_NN 1_CD ,_, leu_NN 2_CD :_: :_: lexA_NN 6_CD op-_NN 
        LEU_NNP 2_LS )_) was_VBD transformed_VBN by_IN the_DT method_NN
        of_IN Gietz_NNP and_CC Schiestl_NNP (_( Agatep_NNP ,_, R_NN ._. ,_, R_NN ._. D_NNP ._. Kirkpatrick_NNP ,_, D_NNP ._. L_NNP ._.
        Parchaliuk_NNP ,_, R_NN ._. A_DT ._. Woods_NNP ,_, and_CC R_NN ._. D_NNP ._. Gietz_NNP (_( 1998_CD )_)
        Transformation_NNP of_IN Saccharomyces_NNP cerevisiae_NN by_IN the_DT lithium_NN
        acetate_NN /_NN single-stranded_JJ carrier_NN DNA_NNP /_NN polyethylene_NN glycol_NN
        (_( LiAc_NNP /_NN ss-_NN DNA_NNP /_NN PEG_NNP )_) protocol_NN ._. Technical_NNP Tips_NNP Online_NNP
        http_NN :_: /_NN /_NN tto_NN ._. trends_NNS ._. com_NN ._. )_) ._. Plasmids_NNP were_VBD maintained_VBN by_IN growth_NN
        in_IN standard_JJ selective_JJ media_NNS ._.
        pVT_NN 560_CD was_VBD constructed_VBN by_IN first_JJ filling_NN the_DT BamHI_NNP and_CC
        XhoI_NNP sites_NNS in_IN pEG_NN 202_CD (_( Gyuris_NNP et_CC ._. al_NN (_( 1993_CD )_) ,_, Cell_NNP
        75_CD :_: 791_CD -_: 803_CD )_) with_IN Klenow_NNP fragment_NN ._. The_DT resulting_VBG vector_NN was_VBD
        digested_VBN with_IN EcoRI_NNP ,_, dephosphorylated_JJ with_IN calf_NN intestinal_NN
        phosphatase_NN (_( CIP_NNP ,_, NEB_NNP )_) ,_, and_CC a_DT PCR_NNP product_NN generated_VBN from_IN
        pVT_NN 27_CD (_( Abedi_NNP et_CC ._. Al_NNP ,_, 1998_CD )_) that_WDT contained_VBD a_DT version_NN of_IN the_DT
        GFP_NNP gene_NN modified_VBN to_TO have_VB Xho_NNP 1_CD and_CC BamHI_NNP sites_NNS located_VBN
        between_IN codons_NNS specifying_VBG N_NNP 157_CD and_CC K_NNP 158_CD ,_, and_CC EcoRI_NNP ends_VBZ
        subsequently_RB inserted_VBN ._. Lastly_NNP an_DT ~_NN 1_CD kb_NN "_'' stuffer_NN "_'' fragment_NN
        containing_VBG most_JJS of_IN the_DT STE_NNP 4_CD gene_NN was_VBD inserted_VBN into_IN the_DT XhoI_NNP
        and_CC BamHI_NNP sites_NNS to_TO aid_VB in_IN purification_NN of_IN doubly_RB digested_VBN
        pVT_NN 560_CD ._.
        The_DT lexA-GFP_JJ /_NN peptide_NN library_NN (_( lVT_NN 560_CD )_) was_VBD created_VBN with_IN
        oligos_NNS oVT_NN 335_CD (_( TCGAGAGTGCAGGT_NNP (_( NN_NNP (_( G_NNP /_NN C_NNP /_NN T_NN )_) )_) 15_CD GGAGCTTCTG_NNP )_) ,_,
        oVT_NN 336_CD (_( ACCTGCACTC_NNP )_) ,_, and_CC oVT_NN 337_CD (_( GATCCAGAAGCTCC_NNP )_) in_IN the_DT
        manner_NN described_VBD in_IN (_( Abedi_NNP et_CC ._. al_NN ,_, 1998_CD )_) ._. LVT_NNP 560_CD is_VBZ
        comprised_VBN of_IN roughly_RB 1_CD ._. 2_CD Ã_NN 10_CD 7_CD ,_, independent_JJ clones_NNS ,_, of_IN
        which_WDT ~_NN 66_CD %_NN contain_VB peptide-encoding_JJ inserts_NNS as_IN judged_VBN by_IN
        restriction_NN digest_VB analysis_NN ._.
        The_DT lexA-peptide_JJ library_NN was_VBD created_VBN in_IN a_DT similar_JJ manner_NN
        to_TO the_DT lexA-GFP_JJ /_NN peptide_NN library_NN except_IN that_IN the_DT sequence_NN
        downstream_JJ of_IN the_DT random_JJ insert_NN contained_VBD stop_VB codons_NNS in_IN
        all_DT three_CD reading_NN frames_NNS ._. A_DT total_NN of_IN 1_CD ._. 5_CD Ã_NN 10_CD 6_CD independent_JJ
        clones_NNS (_( of_IN which_WDT over_IN 95_CD %_NN contain_VB random_JJ peptides_NNS )_) were_VBD
        selected_VBN to_TO indentify_NN transcriptionally_RB active_JJ
        peptides_NNS ._.
        pVT_NN 725_CD was_VBD created_VBN by_IN replacing_VBG the_DT ampicillin_NN
        resistance_NN cassette_NN on_IN pLexA_NN (_( Clontech_NNP )_) with_IN a_DT kanamycin_NN
        resistance_NN gene_NN (_( obtained_VBN from_IN pGBKT_NN 7_CD (_( Clontech_NNP )_) by_IN PCR_NNP )_)
        via_IN homologous_RB recombination_NN in_IN yeast_NN ._.
        The_DT CAS_NNP peptide_NN was_VBD transferred_VBN to_TO pLexA_NN as_IN follows_VBZ :_: Two_CD
        complementary_JJ oligos_NNS which_WDT encoded_JJ the_DT 11_CD amino_JJ acid_NN CAS_NNP
        peptide_NN (_( oVT_NN 2899_CD :_:
        AATTCTGGAGCTTCTGGATCCAAGAATGGAATCAAAGTTAAG_NNP ,_, and_CC oVT_NN 2900_CD :_:
        GGCCGCTTAACTTTGATTCCATTCTTGGATCCAGAAGCTCCAG_NNP )_) were_VBD annealed_JJ
        in_IN PCR_NNP buffer_NN and_CC cloned_VBN using_VBG standard_JJ methods_NNS into_IN pVT_NN 725_CD
        via_IN EcoRI_NNP and_CC NotI_NNP restriction_NN sites_NNS ._. This_DT resulted_VBD in_IN the_DT
        fusion_NN of_IN the_DT CAS_NNP peptide_NN onto_IN the_DT C-_NNP terminus_JJ of_IN lexA_NN ._.
        Transcriptionally_NNP active_JJ peptides_NNS were_VBD selected_VBN by_IN
        transforming_VBG yVT_NN 87_CD with_IN the_DT appropriate_JJ peptide_NN library_NN and_CC
        selecting_VBG for_IN transformants_NNS on_IN plates_NNS lacking_VBG histidine_NN ._.
        Transformants_NNP were_VBD then_RB pooled_VBN and_CC transferred_VBN onto_IN plates_NNS
        lacking_VBG histidine_NN and_CC leucine_NN in_IN order_NN to_TO select_VB for_IN
        peptide_NN sequences_NNS capable_JJ of_IN activating_VBG the_DT
        lexA-operator-driven_JJ 
        LEU_NNP 2_CD reporter_NN ._. DNA_NNP encoding_VBG peptides_NNS
        of_IN interest_NN was_VBD amplified_VBN by_IN PCR_NNP using_VBG oligos_NNS flanking_VBG the_DT
        insert_NN and_CC sequenced_JJ using_VBG an_DT ABI_NNP 377_CD automated_VBN DNA_NNP
        sequencer_NN (_( Applied_NNP Biosystems_NNP )_) ._. Plasmids_NNP were_VBD retested_JJ by_IN
        isolation_NN from_IN yeast_NN using_VBG the_DT phenol_NN /_NN glass_NN bead_NN method_NN
        followed_VBN by_IN electroporation_NN into_IN bacteria_NNS [_NN 32_CD ]_NN ._. The_DT
        plasmids_NNS were_VBD then_RB isolated_VBN from_IN bacteria_NNS using_VBG a_DT
        commercial_JJ DNA_NNP miniprep_NN kit_NN (_( Qiagen_NNP )_) and_CC re-transformed_JJ in_IN
        to_TO yVT_NN 87_CD ._.
      
    
  
